ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

11 links9 made here, not in the record12 judgments2 judges (the rules as one: Rule based)1 record change seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.govMade here
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT04817956Improving Public CancerCare by ImplementingPrecision Medicine inNorwayOslo University HospitalPhase 2 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 8 · ClinicalTrials.gov record · MeSH filing re-derivedMeSH filing re-derivedCONDITIONSNeoplasm MetastasisThe registry's MeSH filing›As of now · Rule based · Main conditionMain conditionDRUGSAtezolizumabIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedTrastuzumabMade here · Found by reading; no entr…›Nov 2 · Claude Opus 5.5 · TestedTestedOlaparibMade here · Found by reading; no entr…›Nov 3 · Claude Opus 5.5 · TestedTestedPertuzumabMade here · Found by reading; no entr…›Nov 3 · Claude Opus 5.5 · TestedTestedNiraparibMade here · Found by reading; no entr…›Nov 3 · Claude Opus 5.5 · TestedTestedAlpelisibMade here · Found by reading; no entr…›Nov 3 · Claude Opus 5.5 · TestedTestedDostarlimabMade here · Found by reading; no entr…›Nov 10 · Claude Opus 5.5 · TestedTestedCobimetinibMade here · Found by reading; no entr…›Nov 10 · Claude Opus 5.5 · TestedTestedAlectinibMade here · Found by reading; no entr…›Nov 10 · Claude Opus 5.5 · TestedTestedEntrectinibMade here · Found by reading; no entr…›Nov 10 · Claude Opus 5.5 · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Atezolizumab

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Atezolizumab”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Tested
Tested · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 2Trastuzumabmade hereClaude Opus 5.5TestedCurrent
Nov 3AtezolizumabClaude Opus 5.5TestedCurrent
Nov 3Olaparibmade hereClaude Opus 5.5TestedCurrent
Nov 3Pertuzumabmade hereClaude Opus 5.5TestedCurrent
Nov 3Niraparibmade hereClaude Opus 5.5TestedCurrent
Nov 3Alpelisibmade hereClaude Opus 5.5TestedCurrent
Nov 8The record itselfClinicalTrials.gov recordMeSH filing re-derivedRecord change
Nov 10Dostarlimabmade hereClaude Opus 5.5TestedCurrent
Nov 10Cobimetinibmade hereClaude Opus 5.5TestedCurrent
Nov 10Alectinibmade hereClaude Opus 5.5TestedCurrent
Nov 10Entrectinibmade hereClaude Opus 5.5TestedCurrent
Nov 18AtezolizumabRule based · role ruleTestedAgrees
As of nowNeoplasm MetastasisRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.